Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Central Institute of Mental Health, Mannheim
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Informed consent given by the subject
DSM-IV-TR diagnosis of schizophrenic psychosis (295.10-30, 295.90)
First documented diagnosis of schizophrenia must not be no older than seven years.
Patients must receive a stable dose of amisulpride, aripiprazole, olanzapine, quetiapine or risperidone (TAU: treatment as usual) at least 4 weeks prior to inclusion in the study to ensure that the maximal effect of the previous medication has been received.
Initial PANSS total score of ≤ 75 at baseline.
proper contraception in female patients of childbearing potential
body mass index between 18 and 40.
You may not be if
Lack of accountability
positive urine drug-screening for illicit drugs at screening (except cannabinoids and benzodiazepines)
serious suicidal risk at screening visit
other relevant interferences of axis 1 according to diagnostic evaluation (MINI) including residual forms of schizophrenia.
other relevant neurological or other medical disorders
pregnancy or lactation.
Clareo Health | Enhancing Recovery in Early Schizophrenia
